Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merisant is a global leader in the manufacturing and marketing of tabletop sweeteners and sugar substitutes, operating in over 90 countries. The company's portfolio features iconic brands such as Equal, Canderel, Pure Via, and Whole Earth, which utilize a variety of sweetening agents including aspartame, stevia, and monk fruit. Originally established in 2000 through the acquisition of Monsanto's sweetener business, Merisant provides essential products for consumers managing metabolic conditions like diabetes and obesity. In 2020, the company became a foundational part of Whole Earth Brands, focusing on the transition toward natural and plant-based sweetening solutions. Merisant maintains a significant global footprint with major operations in North America and Europe, serving retail, food service, and industrial customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merisant.